Transaction · 0001193125-26-409999

Mortimer Ian

MORTIMER IAN, PRES, CEO, reported an open-market or private purchase at Xenon Pharmaceuticals Inc. involving 30000.000000 shares for an estimated $1121400.00. Reported holdings after the transaction were 49923.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PPRES, CEO
XENEXenon Pharmaceuticals Inc.
Trade date
Sep 30, 2026
Filing date
Oct 01, 2026
View on SEC Insider profile
Estimated value$1.12MShares × reported price
Shares traded30.0k$37.38 per share
Holdings after49.9kDirect
% of reported position traded150.58%This security and ownership context
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 19,923 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

XENE price since this filing

Daily closing prices, with the filing date and available return windows
XENE · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +56.0%1w ago -6.1%1d ago -4.3%
Returns since7d -6.5%30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001193125-26-409999
Common Shares
Transaction date
Sep 30, 2026
Filed Oct 01, 2026, 01:19 PM · 1d delay
Shares
30,000 sh
$37.38 per share
Estimated value
$1.12M
Computed from shares × price
Holdings after
49,923 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Director Buy Direct Ownership Large Buy Large Holdings Increase
Filing-only score

+52 points

Compact filing score computed from stored Form 4 facts. Version v1.

Strong filing signal

This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.

How this score is calculated
  • open_market_purchase+12 points

    transaction_code = P

    Code P is a discretionary open-market purchase.
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • ceo_buy+12 points

    is_officer + officer_title/role mentions CEO

    CEO open-market purchase.
  • large_buy_absolute+10 points

    large-buy signal with absolute_triggered = true

    Open-market purchase exceeds the configured absolute threshold.
  • large_holdings_increase+8 points

    large-holdings-increase signal matched

    Reported acquired shares meet the configured percentage of post-transaction holdings.
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

PRESIDENT & CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended

No footnotes recorded.

Original filing · 0001193125-26-409999
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

XENE